Similar Search Results

Cost Effectiveness of Treatment of Parkinson's Disease with Entacapone in the United States

Palmer, Cynthia S.; Nuijten, Mark J.C.; Schmier, Jordana K. - In: PharmacoEconomics 20 (2002) 9, pp. 617-628

Objective: To determine the cost effectiveness of adjunctive therapy with entacapone versus standard treatment (levodopa) without entacapone for patients in the US with Parkinson's disease (PD) who experience `off-time' (re-emergence of the symptoms of PD) while receiving levodopa. Study Design:...

Persistent link: https://www.econbiz.de/10005590388

Cost Effectiveness of Abciximab During Routine Medical Practice

Reed, Shelby Ogilvie; Mullins, C. Daniel; Magder, … - In: PharmacoEconomics 18 (2000) 3, pp. 265-274

Objective: To estimate the cost per ischaemic event (death, nonfatal myocardial infarction, subsequent revascularisation procedure) avoided at 6 months in high risk patients undergoing coronary revascularisation treated with abciximab during routine medical care. Design: Retrospective, matched...

Persistent link: https://www.econbiz.de/10005590464

Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom

Freeman, Hugh; Arikian, Steve; Lenox-Smith, Alan - In: PharmacoEconomics 18 (2000) 2, pp. 143-148

Objective: To estimate the cost effectiveness of different classes of antidepressants in the UK National Health Service. Design, patients and interventions: The use of the serotonin (5-hydroxytryptamine; 5-HT) and noradrenaline (norepinephrine) reuptake inhibitor (SNRI) venlafaxine was compared...

Persistent link: https://www.econbiz.de/10005590475

Cost-Effectiveness Analysis of Topical Calcipotriol versus Short- Contact Dithranol: In the Treatment of Mild to Moderate Plaque Psoriasis

Ashcroft, Darren M.; Li Wan Po, Alain; Williams, Hywel C.; … - In: PharmacoEconomics 18 (2000) 5, pp. 469-476

Objective: To examine the relative cost effectiveness of topical calcipotriol and short-contact dithranol in the treatment of mild to moderate plaque psoriasis. Design and setting: This was a modelling study from the perspective of the UK National Health Service as payer. Methods: The...

Persistent link: https://www.econbiz.de/10005590503

Cost Effectiveness of Zanamivir for the Treatment of Influenza in a High Risk Population in Australia

Mauskopf, Josephine A.; Cates, Sheryl C.; Griffin, Adrian D. - In: PharmacoEconomics 17 (2000) 6, pp. 611-620

Objective: To use data from a clinical trial of zanamivir, a new antiviral drug, to estimate the costs and effectiveness of alternative treatment strategies for a high-risk population in Australia visiting a physician for treatment of influenza or influenza-like illness within 36 hours of...

Persistent link: https://www.econbiz.de/10005590504

Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension: Economic Evaluation of Ramipril Efficacy In Nephropathy (REIN) Study for Germany from the...

Schadlich, Peter K.; Brecht, Josef Georg; Brunetti, Massimo - In: PharmacoEconomics 19 (2001) 5, pp. 497-512

Background: In the Ramipril Efficacy In Nephropathy (REIN) trial, ramipril significantly lowered the rate of reaching the combined end-point of doubling of baseline serum creatinine levels or end-stage renal failure (ESRF). Objective: To determine the additional cost per patient-year of chronic...

Persistent link: https://www.econbiz.de/10005590520

Cost Effectiveness of Combination HIV Therapy: 3 Years Later

Moore, Richard D. - In: PharmacoEconomics 17 (2000) 4, pp. 325-330

Since 1997, expert panel guidelines for HIV care have recommended the use of combination antiretroviral therapy with at least 3 antiretroviral drugs. Several studies have examined the cost effectiveness of 3-drug combination antiretroviral regimens for the treatment of HIV infection. Analyses...

Persistent link: https://www.econbiz.de/10005590539

Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

Sheth, Ketan; Borker, Rohit; Emmett, Amanda; Rickard, … - In: PharmacoEconomics 20 (2002) 13, pp. 909-918

Objective: To compare the relative cost effectiveness of salmeterol (50mug)/ fluticasone propionate (100mug) with that of oral montelukast (10mg) as initial maintenance therapy in patients with persistent asthma uncontrolled on short-acting beta2-agonist therapy alone. Study design: A...

Persistent link: https://www.econbiz.de/10005590542

An Application of a Proposed Framework for Formulary Listing in Low-Income Countries: The Case of Côte d'Ivoire

Diaby, Vakaramoko; Lachaine, Jean - In: Applied Health Economics and Health Policy 9 (2011) 6, pp. 389-402

its current drug reimbursement process because of budgetary constraints. One method of achieving this is to implement a … importance in the decision making around drug reimbursement. Second, a set of priority treatments to be assessed was determined …. Once the treatments eligible for reimbursement were determined, scores were assigned to these treatments according to their …

Persistent link: https://www.econbiz.de/10011005062

Physician Prescribing and Medicare Part D: Closing the Gaps

Shrank, William H. - In: Disease Management and Health Outcomes 15 (2007) 2, pp. 69-71

Persistent link: https://www.econbiz.de/10005243015